Clinical trial
A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of…
NCT00483041 · MedImmune LLC, Industry · Terminated
Key facts
| NCT number | NCT00483041 |
|---|---|
| Title | A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528 |
| Official title | A Phase2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528, A Humanized Anti-Interleukin-9 Monoclonal Antibody, on Allergen-Induced Interleukin-9 Levels in Bronchoalveolar Lavage Fluid in Adults With Atopic Asthma |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Biological, Other |
| Interventions | PLACEBO, MEDI528 9 mg/kg |
| Enrollment | 11 |
| Start date | Jul 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Jun 6, 2007 |
| Last update posted | Mar 7, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: